Notice: This company has been marked as potentially delisted and may not be actively trading. Miragen Therapeutics (MGEN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends MGEN vs. SERA, BDSX, XGN, BNR, ENZ, OPGN, BGLC, FRES, ACON, and MDXHShould you be buying Miragen Therapeutics stock or one of its competitors? The main competitors of Miragen Therapeutics include Sera Prognostics (SERA), Biodesix (BDSX), Exagen (XGN), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), OpGen (OPGN), BioNexus Gene Lab (BGLC), Fresh2 Group (FRES), Aclarion (ACON), and MDxHealth (MDXH). Miragen Therapeutics vs. Sera Prognostics Biodesix Exagen Burning Rock Biotech Enzo Biochem OpGen BioNexus Gene Lab Fresh2 Group Aclarion MDxHealth Sera Prognostics (NASDAQ:SERA) and Miragen Therapeutics (NASDAQ:MGEN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment. Does the media favor SERA or MGEN? In the previous week, Sera Prognostics had 6 more articles in the media than Miragen Therapeutics. MarketBeat recorded 6 mentions for Sera Prognostics and 0 mentions for Miragen Therapeutics. Sera Prognostics' average media sentiment score of 0.87 beat Miragen Therapeutics' score of 0.00 indicating that Sera Prognostics is being referred to more favorably in the media. Company Overall Sentiment Sera Prognostics Positive Miragen Therapeutics Neutral Do analysts recommend SERA or MGEN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Miragen Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings and valuation, SERA or MGEN? Sera Prognostics has higher earnings, but lower revenue than Miragen Therapeutics. Sera Prognostics is trading at a lower price-to-earnings ratio than Miragen Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSera Prognostics$310K723.33-$36.24M-$0.99-6.71Miragen Therapeutics$4.46M16.13-$41.87M-$20.09-0.92 Do insiders and institutionals hold more shares of SERA or MGEN? 54.6% of Sera Prognostics shares are owned by institutional investors. 15.8% of Sera Prognostics shares are owned by insiders. Comparatively, 1.1% of Miragen Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is SERA or MGEN more profitable? Sera Prognostics has a net margin of 0.00% compared to Miragen Therapeutics' net margin of -1,393.50%. Sera Prognostics' return on equity of -51.73% beat Miragen Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sera PrognosticsN/A -51.73% -36.94% Miragen Therapeutics -1,393.50%-141.66%-88.74% Which has more volatility and risk, SERA or MGEN? Sera Prognostics has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Miragen Therapeutics has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Does the MarketBeat Community believe in SERA or MGEN? Miragen Therapeutics received 257 more outperform votes than Sera Prognostics when rated by MarketBeat users. Likewise, 70.45% of users gave Miragen Therapeutics an outperform vote while only 38.46% of users gave Sera Prognostics an outperform vote. CompanyUnderperformOutperformSera PrognosticsOutperform Votes1038.46% Underperform Votes1661.54% Miragen TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% SummarySera Prognostics beats Miragen Therapeutics on 12 of the 17 factors compared between the two stocks. Get Miragen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGEN vs. The Competition Export to ExcelMetricMiragen TherapeuticsMedical Laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.95M$3.06B$5.39B$9.13BDividend YieldN/A16.58%5.37%4.00%P/E Ratio-1.7316.0788.9117.53Price / Sales16.13204.421,290.81137.24Price / CashN/A393.5036.6032.90Price / Book2.725.244.964.69Net Income-$41.87M-$33.85M$117.89M$224.57M Miragen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGENMiragen TherapeuticsN/A$18.41+1.5%N/A-9.8%$71.95M$4.46M-1.7345High Trading VolumeSERASera Prognostics0.682 of 5 stars$6.42-2.7%N/A+10.7%$216.80M$310,000.00-6.48120BDSXBiodesix3.8194 of 5 stars$1.15+0.9%$3.06+166.1%-43.7%$167.29M$49.09M-2.95220Positive NewsXGNExagen4.6836 of 5 stars$3.99+30.4%$7.50+88.0%+102.5%$70.38M$52.55M-4.24220High Trading VolumeBNRBurning Rock Biotech2.1898 of 5 stars$6.75+3.8%N/A-24.4%$69.07M$75.70M-2.251,390Short Interest ↓Positive NewsGap UpENZEnzo Biochem1.6301 of 5 stars$0.66-1.4%N/A-50.7%$34.27M$31.91M0.00520OPGNOpGenN/A$1.73+20.1%N/A-54.3%$14.46M$3.42M0.00100Analyst ForecastBGLCBioNexus Gene Lab0.4991 of 5 stars$0.38-0.7%N/A-27.5%$6.78M$9.77M0.0030Positive NewsGap UpFRESFresh2 GroupN/A$0.85flatN/AN/A$765,000.00$1.75M0.0075ACONAclarion1.689 of 5 stars$0.04-6.0%$1.30+2,973.3%-98.5%$524,000.00$80,000.000.007High Trading VolumeMDXHMDxHealth1.9692 of 5 stars$1.96-1.5%$7.00+257.1%-46.4%$0.00$70.19M-1.29300 Related Companies and Tools Related Companies Sera Prognostics Alternatives Biodesix Alternatives Exagen Alternatives Burning Rock Biotech Alternatives Enzo Biochem Alternatives OpGen Alternatives BioNexus Gene Lab Alternatives Fresh2 Group Alternatives Aclarion Alternatives MDxHealth Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MGEN) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miragen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Miragen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGEN Stock Alerts